How much does weight-loss medication cost in the Netherlands in 2026?

If you’ve been eyeing weight-loss jabs and wondering what they’ll do to your bank balance, the short answer is that you’ll likely be paying yourself, somewhere between €150 and €400 a month, depending on the medication.

Weight-loss medication has gone from niche to nearly impossible to avoid in conversations about, sorry for repeating myself, losing weight.

But there’s a big gap between hearing about these treatments and knowing what they’ll actually cost you here in the Netherlands. So let’s break it down.

First, what exactly are “weight-loss drugs”?

The “weight-loss jabs” everyone means are GLP-1 receptor agonists. They mimic a hormone your body releases after eating, the one that tells your brain you’re full. Less hunger, less eating, and often weight loss.

They were developed for type 2 diabetes, which is where the cost confusion starts. The same medication can be fully covered or entirely out of pocket, depending on why and when you’re taking it.

The big question: will my insurance cover it?

For most people using GLP-1 medication purely to lose weight, the answer in 2026 is probably no.

With a type 2 diabetes diagnosis, all eight major Dutch insurers cover it through the basic insurance (basisverzekering), and you’ll only pay your eigen risico — the €385 deductible.

Without that diagnosis, you’re usually paying yourself.

When weight-loss medication is covered

Weight-loss GLP-1 medication could be covered if you have:

• a BMI of 35-plus with a related condition (or 40-plus on its own),
• a year on a recognised lifestyle programme (a Gecombineerde Leefstijlinterventie; it’s also great for winning Dutch Scrabble) without enough result,
• and a doctor’s prescription.

So yeah, if you’re reading this, you probably tried a ton of lifestyle changes already, and it’s at least a year away.

And even then, you pay your €385 deductible first (or more, if you like to live dangerously and have a higher deductible sum)

What do weight-loss drugs cost out of pocket?

If you don’t qualify for coverage, here’s roughly what you’re looking at per month in 2026. These are indicative figures, since prices shift with dosage and pharmacy:

• A common GLP-1 medication used off-label for weight loss: around €150 to €250
• A daily-injection option developed for weight loss: roughly €250 to €300
• A newer weight-loss treatment: around €250 to €350
• A dual-hormone treatment (it mimics a second hormone for a potentially stronger effect): around €400

These aren’t one-off costs, either. GLP-1 treatment is typically ongoing, so the monthly figure is the one that matters.

Why isn’t this just covered already?

Fair question, especially when CBS reports that half of Dutch adults had excess weight in 2024, with 16% in the obesity category.

The honest answer is cost and scale. Covering these medications for everyone who wants them would put enormous pressure on the healthcare budget, so the line sits at medical necessity rather than general weight loss.

Whether that line moves is an open question. Some weight-loss medication could be added to basic insurance later in 2026, but nothing is locked in yet.

How can internationals actually access it?

If you don’t qualify for coverage but still want to explore GLP-1 treatment, you’ve got two routes.

The first is your huisarts (GP), who can check whether you meet the conditions and point you toward a lifestyle programme if it fits.

The second is a private clinic or online platform. You complete a health questionnaire, a BIG-registered doctor reviews your eligibility, and if approved, treatment is prescribed and delivered.

It’s a more personalised route, with the trade-off that you cover the cost yourself.

Have you looked into weight-loss medication while living in the Netherlands, or been surprised by what your insurance does and doesn’t cover? Tell us in the comments below.